2020AOn October 7-9, 2011, 150 Pompe patients and their families, scientists, doctors, and industry representatives from around the world gathered
Excerpt from August 30, 2010 press release . . . BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has
Hi All, The AMDA has been working with Pfizer on supporting some proposed legislation in California that is intended to
August 10, 2011
News August 2010 Pompe Program Update from Genzyme
Genzyme would like to provide an update to the US Pompe community regarding the transition to commercial LumizymeTM (alglucosidase alfa)
July 12, 2011
2011 AMDA Pompe Disease Research Grant Opportunity
The AMDA is excited to announce a research grant opportunity for applicants who are involved in Pompe Disease research. This